Michael Milburn Founder of GeneCentric Therapeutics Backed byAlexandria Venture InvestmentsPeter M. Moglia LinkedIn SourcesGeneCentric Therapeutics Announces American Medical Association Has Granted a PLA Code for PurIST Pancreatic Cancer Test — 2025-06 Browse all founders · Browse investors
